Cancer is induced by the accumulation of harmful DNA mutations in cells. At present, the mechanisms of inducing abnormal cell proliferation, differentiation and cancer production are mainly studied in three categories: activating dominant transforming proto-oncogenes by translocations and mutations, inactivating tumor suppressor gene by mutations, and disordering the DNA repair genes.
CD Genomics provides a predesigned cancer hotspot gene panel sequencing utilizing amplicon sequencing technology by illumina system, which covers a total of 65 common proto-oncogenes and tumor suppressor genes associated with the common human cancer, such as breast cancer, lung cancer and colorectal cancer. And also, you can choose the genes from the gene list to customize your exclusive sequencing and bioinformatics analysis for researches.
ABL1 | AKT1 | ALK | APC | ATM | BRAF | BRCA1 | BRCA2 | CDH1 | CDKN2A |
CSF1R | CTNNB1 | DDR2 | DNMT3A | EGFR | ERBB2 | ERBB3 | ERBB4 | EZH2 | FBXW7 |
FGFR1 | FGFR2 | FGFR3 | FLT3 | FOXL2 | GNA11 | GNAQ | GNAS | HNF1A | HRAS |
IDH1 | IDH2 | JAK2 | JAK3 | KDR | KIT | KRAS | MAP2K1 | MET | MLH1 |
MPL | MSH6 | MTOR | NF1 | NF2 | NOTCH1 | NPM1 | NRAS | PDGFRA | PIK3CA |
PIK3R1 | PTCH1 | PTEN | PTPN11 | RB1 | RET | SMAD4 | SMARCB1 | SMO | SRC |
STK11 | TERT | TP53 | TSC1 | VHL |
Sample Requirements
|
|
Sequencing
|
|
Bioinformatics Analysis We provide customized bioinformatics analysis including:
|
CD Genomics provides the accurate and cost-effective cancer hotspot panel sequencing and bioinformatics analysis. Our professional expert team executes quality management, following every procedure to ensure confident and unbiased results. The general workflow for cancer hotspot panel sequencing is outlined below.
For more information about the cancer hotspot panel or need other amplification requirements, please contact us.
Reference: